Nanodimension Iii, L.P. bought ICVX once, on Aug 2, 2021

NanoDimension III, L.P. is a limited partnership investment fund affiliated with ND Capital (formerly NanoDimension), a venture capital firm that invests in disruptive technologies across the life, physical, and data sciences.( As an institutional investor, NanoDimension III, L.P. has held significant positions in emerging life-science companies, including Icosavax, Inc. (ICVX), where it was previously reported as a 10% beneficial owner under U.S. securities regulations.( Form 4 filings with the U.S. Securities and Exchange Commission identify NanoDimension III, L.P. as the reporting person, with NanoDimension III Management Ltd. serving as its general partner, reflecting a typical venture fund structure in which a management entity controls investment and governance decisions.(

Through its association with ND Capital, NanoDimension III, L.P. participates in early- and growth-stage financings of technology-focused companies, providing capital and strategic support aimed at long-term value creation.( At Icosavax, the fund’s stake and subsequent transactions, disclosed in SEC insider trading reports, marked it as a key shareholder during the company’s development and prior to its acquisition agreement with AstraZeneca.( Leadership and day-to-day operations of NanoDimension III, L.P. are overseen by its general partner, NanoDimension III Management Ltd., and by the broader ND Capital management team, which collectively direct portfolio strategy and investment activities.(

Written by Perplexity from public sources.